USPTO 2015–2025 USPTO PatentsView US Corporation

Immunolight, Llc

USPTO PatentsView assignee record - 97 granted patents across 52 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

51.1

Avg claims per patent

-6%

5-year filing velocity

The verdict

Immunolight holds 97 US patents across 52 technology areas, rank #3,734 of 50,000 tracked assignees.

#3,734
of 50,000 US assignees by volume: Top 3%
by Innovation Score (61.3/100): 51.1
avg claims per patent: -6%
filing velocity, last 5 yrs

Portfolio overview

Immunolight, Llc has been granted 97 US utility patents between 2015 and 2025, placing Immunolight, Llc at rank #3,734 across all assignees tracked by PlainPatent. This portfolio spans 52 distinct Cooperative Patent Classification (CPC) subclasses, averaging 51.1 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Immunolight, Llc is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Immunolight sits between DSP Group Ltd. (97 patents, rank #3,730) and Mobile Technology Corporation (97 patents, rank #3,738) - the closest US assignees by grant volume. The composite Innovation Score of 61.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 47 grants, compared with 50 in the 2015–2019 window, a -6% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Immunolight, Llc's 51.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 52 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Immunolight, Llc against peers pursuing similar technology classes.

DSP Group

97
Dynasty Footwear

97
Eppendorf

97
Harbor Freight To…

97
Koninklijke Phili…

97
Korea Institute o…

97
LORD

97
Mobile Technology

97
Immunolight ◀

97

What this shows Immunolight holds 97 patents at rank #3,734, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immunolight

By rank, the assignees closest to #3,734 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Immunolight's primary technology class.

Immunolight's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Immunolight, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	6.2%
2016	11	11.3%
2017	9	9.3%
2018	10	10.3%
2019	14	14.4%
2020	11	11.3%
2021	8	8.2%
2022	11	11.3%
2023	7	7.2%
2024	9	9.3%
2025	1	1.0%

Which technologies does Immunolight, Llc patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 72

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 64

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 51

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 40

C09J - ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES 40

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 31

Y02W - CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT 30

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 29

A23B - PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES 28

C02F - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE 26

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 23

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 22

C08J - WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H 22

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 22

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 21

Top 15 of 52 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Declining

Where it ranks

Overall rank by patents

#3,734

Across all tracked assignees

Innovation Score

61.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Immunolight, Llc hold?

Immunolight, Llc holds 97 US granted patents filed between 2015 and 2025, spanning 52 technology areas.

What is Immunolight, Llc's Innovation Score?

Immunolight, Llc has an Innovation Score of 61.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Immunolight, Llc focus on?

Immunolight, Llc's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 72 patents. The company has filed patents in 52 CPC subclasses total.

Is Immunolight, Llc's patent filing rate increasing or decreasing?

Immunolight, Llc's recent filing velocity is -6% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Immunolight, Llc's patents?

Immunolight, Llc's patents average 51.1 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Immunolight, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Immunolight's 97 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Immunolight ranks #3,734 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.